Intas inks pacts with Japanese, Korean firms for biosimilar product
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Investegate |Competition and Mkts Announcements | Competition and Mkts: CMA finds drug companies overcharged NHS
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Search jobs 04-May-2021 Injectable Benzodiazepine Market 2021 Analysis By Regional, Outlook, Competitive Landscape Strategies And Forecast 2030 | Akorn Inc, Pfizer Inc., AdvaCare Pharma, Dash Pharmaceuticals LLC & so on…
Future Market Insight’s projections reveal that the global injectable benzodiazepine market is set to shoot up significantly in 2020, reaching a value of US$ 260 Mn in the wake of the coronavirus pandemic.
Benzodiazepines are a class of psychoactive drugs used to reduce anxiety amongst patients. As the pandemic tightens its grip each day, stress levels among individuals regarding the threat is increasing. Massive layoffs from jobs across various industries due to lockdowns is leading to increased cases of depression. Without jobs, people are unable to sustain their families, which is putting enormous strain on their mental and physical well-being. Therefore, consumption of anti-depressant drugs containing ben
Eris Lifesciences Limited reappoints MD and Whole-Time Director
Posted On: 2021-04-01 03:01:53 (Time Zone: Arizona, USA)
Based on the recommendation of the Nomination and Remuneration Committee and their own consideration, the Board of Directors of Eris Lifesciences Limited at their meeting held on 31st March 2021 has approved the re-appointment of Mr. Amit Bakshi (DIN: 01250925) as a Managing Director of the Company for a further period of five (5) years with effect from April 1st 2021, subject to the approval of the shareholders, in the usual course.
The board also approved the re-appointment of Mr. Inderjeet Singh Negi (DIN: 01255388) as a Whole-Time Director of the Company for a further period of five (5) years with effect from April 1st 2021, subject to the approval of the shareholders, in the usual course.